mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.06 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.07 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.098 |
0.07 |
mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
-0.24 |
0.07 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.07 |